Therapeutic approach in early and late ARDS.
Suter
P
P
University Hospital, Genève, Switzerland.
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D015765:Almitrine / Q000008:administration & dosage / Q000627:therapeutic use; D005466:Fluorocarbons / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006935:Hypercapnia / Q000503:physiopathology; D007040:Hypoventilation / Q000503:physiopathology; D007275:Injections, Intravenous; D008168:Lung / Q000473:pathology / Q000503:physiopathology; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use; D011175:Positive-Pressure Respiration; D016684:Prone Position; D011650:Pulmonary Alveoli / Q000503:physiopathology; D011659:Pulmonary Gas Exchange / Q000502:physiology; D011663:Pulmonary Surfactants / Q000627:therapeutic use; D012128:Respiratory Distress Syndrome / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D015656:Respiratory Mechanics / Q000502:physiology; D019141:Respiratory System Agents / Q000008:administration & dosage / Q000627:therapeutic use; D013500:Surface Tension; D014692:Ventilation-Perfusion Ratio
D000305:Adrenal Cortex Hormones; D005466:Fluorocarbons; D011663:Pulmonary Surfactants; D019141:Respiratory System Agents; D009569:Nitric Oxide; D015765:Almitrine